[Trial of a new synthetic fluidifying and analeptic agent: sobrerol. Its use in inflammatory bronchopneumopathies].
D000328:Adult; D000368:Aged; D001991:Bronchitis / Q000188:drug therapy*; D001996:Bronchopneumonia / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002908:Chronic Disease; D003510:Cyclohexanes / Q000627:therapeutic use*; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000188:drug therapy*; D012129:Respiratory Function Tests; D012131:Respiratory Insufficiency / Q000188:drug therapy
D000697:Central Nervous System Stimulants; D003510:Cyclohexanes; D005100:Expectorants
Sperimentazione di un nuovo fluidificante e analettico di sintesi: il sobrerolo. Sua utilità nelle broncopneumopatie flogistiche.